(Q37981990)

26 August 2017

title

Flow cytometry in cancer stem cell analysis and separation (English)

1 reference

26 August 2017

1 reference

neoplastic stem cells

1 reference

Burkhard Greve

1

1 reference

26 August 2017

Reinhard Kelsch

2

1 reference

26 August 2017

Kristina Spaniol

3

1 reference

26 August 2017

Hans Theodor Eich

4

1 reference

26 August 2017

Martin Götte

5

1 reference

26 August 2017

publication date

6 February 2012

1 reference

26 August 2017

1 reference

26 August 2017

volume

81

1 reference

26 August 2017

issue

4

1 reference

26 August 2017

page(s)

284-293

1 reference

Cancer stem cells in gliomas: identifying and understanding the apex cell in cancer's hierarchy

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Stem cells, cancer, and cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Understanding the cancer stem cell.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Die hard: are cancer stem cells the Bruce Willises of tumor biology?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Cancer stem cells and cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

The biology of cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Hypoxia inducible factors in cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

The difficulty of targeting cancer stem cell niches

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Clinical significance of side population in ovarian cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Metastatic cancer stem cells: new molecular targets for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Prospective identification of tumorigenic breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Cancerous stem cells can arise from pediatric brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Prospective identification of tumorigenic prostate cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Prostate cancer stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Identification and characterization of tumorigenic liver cancer stem/progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

An increase in cancer stem cell population after primary systemic therapy is a poor prognostic factor in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Exploring the role of cancer stem cells in radioresistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Side population and cancer stem cells: therapeutic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Association of reactive oxygen species levels and radioresistance in cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Prostate cancer stem cells: a new target for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

A distinct "side population" of cells with high drug efflux capacity in human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

CD133(-) cells, derived from a single human colon cancer cell line, are more resistant to 5-fluorouracil (FU) than CD133(+) cells, dependent on the β1-integrin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Phenotypes of stem cells from diverse origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

A tumorigenic subpopulation with stem cell properties in melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Head and neck cancer stem cells: the side population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

SP analysis may be used to identify cancer stem cell populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

ALDH1 as a functional marker of cancer stem and progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Rare Event Detection and Analysis in Flow Cytometry: Bone Marrow Mesenchymal Stem Cells, Breast Cancer Stem/Progenitor Cells in Malignant Effusions, and Pericytes in Disaggregated Adipose Tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

A novel true volumetric method for the determination of residual leucocytes in blood components

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Optimized flow cytometric analysis of central nervous system tissue reveals novel functional relationships among cells expressing CD133, CD15, and CD24.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Prospective isolation of human MSC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Cancer stem cells: markers or biomarkers?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Current status and issues in cancer stem cell study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Cancer stem cell markers in common cancers - therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

A human colon cancer cell capable of initiating tumour growth in immunodeficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Expression of HOXC9 and E2F2 are up-regulated in CD133(+) cells isolated from human astrocytomas and associate with transformation of human astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Identification of human brain tumour initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

A cell initiating human acute myeloid leukaemia after transplantation into SCID mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

CD90/Thy-1 is preferentially expressed on blast cells of high risk acute myeloid leukaemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Stem-like cells in bone sarcomas: implications for tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Release of extracellular membrane particles carrying the stem cell marker prominin-1 (CD133) from neural progenitors and other epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Localization of CD44 and CD90 positive cells to the invasive front of breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Identification and expansion of human colon-cancer-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Phenotypic characterization of human colorectal cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

CD133+CD44+ population efficiently enriches colon cancer initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Highly enriched CD133(+)CD44(+) stem-like cells with CD133(+)CD44(high) metastatic subset in HCT116 colon cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Epigenetic regulation of CD133 and tumorigenicity of CD133 positive and negative endometrial cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

The adult stem cell marker Musashi-1 modulates endometrial carcinoma cell cycle progression and apoptosis via Notch-1 and p21WAF1/CIP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

CD44+CD133+population exhibits cancer stem cell-like characteristics in human gallbladder carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Identification of gastric cancer stem cells using the cell surface marker CD44.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Significance of CD90+ cancer stem cells in human liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Identification and characterization of ovarian cancer-initiating cells from primary human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Identification of pancreatic cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

CD44+ CD24(-) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Characterization of benign and malignant prostate epithelial Hoechst 33342 side populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Cancer stem cells in head and neck squamous cell cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Expression of CD176 (Thomsen-Friedenreich antigen) on lung, breast and liver cancer-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

The Wnt/beta-catenin pathway is required for the development of leukemia stem cells in AML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Proteomic analysis of pathways involved in estrogen-induced growth and apoptosis of breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Cancer genes and the pathways they control

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Cancer stem cells versus phenotype-switching in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Hypomethylation of CD30 CpG islands with aberrant JunB expression drives CD30 induction in Hodgkin lymphoma and anaplastic large cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Defining the steps that lead to cancer: replicative telomere erosion, aneuploidy and an epigenetic maturation arrest of tissue stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Marrow stem cells shift gene expression and engraftment phenotype with cell cycle transit

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Local conformation and dynamics of isoleucine in the collagenase cleavage site provide a recognition signal for matrix metalloproteinases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

More than markers: biological significance of cancer stem cell-defining molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

ABCG2: a potential marker of stem cells and novel target in stem cell and cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Survival of the fittest: cancer stem cells in therapeutic resistance and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Tumour stem cells and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Multiple drug resistance in cancer revisited: the cancer stem cell hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Breast cancer chemoresistance: emerging importance of cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

AP-1-Dependent miR-21 expression contributes to chemoresistance in cancer stem cell-like SP cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Using ABCG2-molecule-expressing side population cells to identify cancer stem-like cells in a human ovarian cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Side populations of glioblastoma cells are less sensitive to HSV-TK/GCV suicide gene therapy system than the non-side population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

B-chronic lymphocytic leukemia chemoresistance involves innate and acquired leukemic side population cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Flow cytometric characterization of the DAOY medulloblastoma cell line for the cancer stem-like phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Side population cells in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Replacing Hoechst33342 with rhodamine123 in isolation of cancer stem-like cells from the MHCC97 cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

A multidrug resistance transporter from human MCF-7 breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Flow cytometry-based approach to ABCG2 function suggests that the transporter differentially handles the influx and efflux of drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Side population analysis using a violet-excited cell-permeable DNA binding dye.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Identification of cancer stem-like side population cells in ovarian cancer cell line OVCAR-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Isolation and identification of a distinct side population cancer cells in the human epidermal squamous cancer cell line A431.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Factors influencing the abundance of the side population in a human myeloma cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Demystifying SP cell purification: viability, yield, and phenotype are defined by isolation parameters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Kinetic analyses as a critical parameter in defining the side population (SP) phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

The presence of ABCG2-dependent side population cells in human periodontal ligaments

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Human aldehyde dehydrogenases: potential pathological, pharmacological, and toxicological impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Molecular signatures of prostate stem cells reveal novel signaling pathways and provide insights into prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

ALDH1A1 and ALDH3A1 expression in lung cancers: correlation with histologic type and potential precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Identification of human aldehyde dehydrogenase 1 family member A1 as a novel CD8+ T-cell-defined tumor antigen in squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

The power and the promise of liver cancer stem cell markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Side population is not necessary or sufficient for a cancer stem cell phenotype in glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

The combined use of Hoechst efflux ability and aldehyde dehydrogenase activity to identify murine and human hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Dual SP/ALDH functionalities refine the human hematopoietic Lin-CD34+CD38- stem/progenitor cell compartment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Aldehyde dehydrogenase-1 is a specific marker for stem cells in human lung adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Identification of cancer stem-like CD44+ cells in human nasopharyngeal carcinoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Flow Cytometry: An Introduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

International Society for Analytical Cytology biosafety standard for sorting of unfixed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Short-term physiologic effects of mechanical flow sorting and the Becton-Dickinson cell concentrator in cultures of the marine phytoflagellata Emiliania huxleyi and Micromonas pusilla

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Epigenetic gene regulation in stem cells and correlation to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Clinical implications of stem cell gene Oct-4 expression in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Notch signalling in cancer stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Proliferation and differentiation of neuronal stem cells regulated by nerve growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Nanog-induced dedifferentiation of p53-deficient mouse astrocytes into brain cancer stem-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Simultaneous detection of mRNA and protein stem cell markers in live cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Peptide-linked molecular beacons for efficient delivery and rapid mRNA detection in living cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Dual FRET molecular beacons for mRNA detection in living cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Identification of a tumor-initiating stem cell population in human renal carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Distinct patterns of hematopoietic stem cell involvement in acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

Markedly increased Oct4 and Nanog expression correlates with cisplatin resistance in oral squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

7 January 2021

Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

7 January 2021

CD44: A Cancer Stem Cell–Related Biomarker with Predictive Potential for Radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

7 January 2021

An improved flow cytometric assay for detection and discrimination between malignant cells and atypical mesothelial cells, in serous cavity effusions

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

7 January 2021

The impact of erythrocyte lysing procedures on the recovery of hematopoietic progenitor cells in flow cytometric analysis

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

7 January 2021

Prostate cancer stem cells: a target for new therapies

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

7 January 2021

Phenotypic change of human cultured meningioma cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

7 January 2021

Purification and unique properties of mammary epithelial stem cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

7 January 2021

Separation of pancreatic islets by fluorescence-activated sorting

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22022

7 January 2021

Identifiers

DOI

10.1002/CYTO.A.22022

1 reference

26 August 2017

1 reference